New Delhi, March 25 The initial public offering of Sai Parenteral's Ltd, a diversified pharmaceutical formulation company, saw 41 per cent subscription on the second day of the share sale on Wednesday.The IPO received bids for 30,82,788 shares against 75,22,486 shares on offer, according to...
anchor investors
contract development and manufacturing organization
equity shares
global formulations
initial public offering
injectable products
ipo subscription
new delhi
oral solid dosage formulations
pharmaceutical formulation
price band
qualified institutional buyers
retail individual investors
sai parenteral's ltd
share sale
Sai Parenteral’s IPO Price Band Set at ₹372 to ₹392 per Share, Targets ₹285 Crore Fresh Issue
Company Files RHP with SEBI and Stock Exchanges
Sai Parenteral’s Ltd, a diversified pharmaceutical formulation company, has announced the price band for its upcoming Initial Public Offering, setting it...
business expansion
contract development and manufacturing organisation
corporate finance
equity shares
financial
global formulations
initial public offering
injectable products
investment
ipo
oral solid dosage formulations
pharmaceutical formulation
red herring prospectus
sai parenteral's ltd
securities and exchange board of india
stock exchange